MaxCyte Inc (MXCT)

London
Currency in GBP
382.00
-23.00(-5.68%)
Closed
MXCT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
380.00403.60
52 wk Range
259.14413.00
Key Statistics
Edit
Bid/Ask
380.00 / 410.00
Prev. Close
405
Open
405
Day's Range
380-403.6
52 wk Range
259.14-413
Volume
24.95K
Average Volume (3m)
66.72K
1-Year Change
-3.9%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MXCT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
622.04
Upside
+62.84%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

MaxCyte Company Profile

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 622.04
(+62.84% Upside)

Earnings

Latest Release
Mar 22, 2022
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the MaxCyte (MXCT) Stock Price Today?

The MaxCyte stock price today is 382.00.

What Stock Exchange Does MaxCyte Trade On?

MaxCyte is listed and trades on the London stock exchange.

What Is the Stock Symbol for MaxCyte?

The stock symbol for MaxCyte is "MXCT."

What Is the MaxCyte Market Cap?

As of today, MaxCyte market cap is 403.82M.

What is MaxCyte Earnings Per Share?

The MaxCyte EPS is -0.342.

From a Technical Analysis Perspective, Is MXCT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.